Antidysrhythmics Flashcards
Class I
Na+ channel blockers; overall slow down conduction and decrease the slope of phase 0 depolarization
Class Ia
Delay repolarization; moderate
Class Ib
Accelerate repolarization; weak
Class Ic
Reduce conduction velocity; strong
Class II
Beta blockers
Class III
K+ channel blockers
Class IV
Ca++ channel blockers
Quinidine, procainamide
Class Ia: Na+ channel blockers
Mechanism: increases AP, ERP, and QT interval
Indication: atrial and ventricular arrhythmias (SVTs and VTs)
Adverse Effects: cholinergic effects (increase HR, etc)
Lidocaine
Class Ib: Na+ channel blocker
Mechanism: decreases AP, ERP, allowing for a more coordinated contraction
Indication: post-MI and other ventricular arrhythmias
Adverse Effects: toxicity at high doses
Propanolol, metoprolol, esmolol
Class II: beta blockers
Mechanism: block b1 receptors to decrease HR, contractility, and AV conduction
Indication: afib, SVTs, VTs, post-MI (to improve O2 supply/demand and decrease cardiac modeling)
Amiodarone
Class III: K+ channel blockers
Mechanism: block K+ exit, which delays depolarization, increases AP duration, and increases ERP
PK: long 1/2 life
Indications: ventricular tachycardias (vfib and vtach)
Contraindications: pregnancy, drug interactions
Adverse Effects: pulmonary fibrosis, prodysrhythmic (torsades, bradycardia, AV block)
Verapamil, diltiazem
Class IV: Ca++ channel blockers
Nondihydropyridines
Mechanism: block Ca++ influx, which decreases HR, contractility, and AV node conduction (like beta blockers)
Indications: afib, SVTs
Contraindications: avoid concurrent admin of CCB and BB)
Adverse Effects: bradycardia, AV block, hypotension
Adenosine
Mechanism: binds adenosine receptor in cardiac tissue, causing hyper polarization and basically stops the heart
PK: super short 1/2 life…must be given rapid IVP followed by flush
Indications: afib (supra-), SVT
Adverse Effects: flushing, transient hypotension, transient cessation of electrical activity
Digoxin
Class: cardiac glycoside
Mechanism: potent Na+/K+ ATPase inhibitor, resulting in increase contractility (inotropy)
Indications: afib (supra-), SVT
Contraindications: heart block, hypokalemia (causes digoxin toxicity), WPW, advanced CKD
Atropine
Class: anticholinergic
Mechanism: muscarinic receptor antagonism, causing increased HR
Indications: symptomatic bradycardia, complete heart block
Adverse Effects: anticholinergic s/s